Skip to main content

Advertisement

Log in

Association Between Alzheimer Disease and the −491T Allele of Regulatory Region Polymorphism of Apolipoprotein E in a Tunisian Population

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The apolipoprotein E (APOE) is a well-established risk factor for late-onset Alzheimer’s disease (AD). Several studies have attempted to confirm the association between the polymorphism located at position −491 in the transcriptional regulatory region of the APOE gene and AD. We examined in 85 AD patients and 90 control subjects of a Tunisian population the potential involvement of this polymorphism as a risk factor for AD, either through an independent effect or through interaction with the existing APOE ε4 allele risk. The T allele frequency was significantly higher in the AD patients group (45.3 %) than in the controls group (32.78 %) and may possibly constitute a significant risk factor for AD. The APOE ε4 allele did not influence the distribution of the −491 polymorphism after stratification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Valenza A, Bizzarro A, Marra C, Lauria A, Guglielmi V, Rossi C, Tiziano FD, Brahe C, Masullo C (2010) The APOE −491A/T promoter polymorphism effect on cognitive profile of Alzheimer’s patients. Neurosci Lett 472(3):199–203. doi:10.1016/j.neulet.2010.02.004

    Article  CAS  PubMed  Google Scholar 

  2. Lynch CA, Brazil J, Cullen B, Coakley D, Gill M, Lawlor BA, Hawi Z (2008) Apolipoprotein E promoter polymorphisms (−491A/T and −427T/C) and Alzheimer’s disease: no evidence of association in the Irish population. Ir J Med Sci 177(1):29–33. doi:10.1007/s11845-007-0098-7

    Article  CAS  PubMed  Google Scholar 

  3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123):921–923

    Article  CAS  PubMed  Google Scholar 

  4. Xin XY, Ding JQ, Chen SD (2010) Apolipoprotein E promoter polymorphisms and risk of Alzheimer’s disease: evidence from meta-analysis. J Alzheimers Dis 19(4):1283–1294. doi:10.3233/jad-2010-1329

    CAS  PubMed  Google Scholar 

  5. Rassas AA, Mrabet Khiari H, Hadj Fredj S, Sahnoun S, Batti H, Zakraoui NO, Cherif A, Anane N, Ben Ali N, Messaoud T, Mrabet A (2012) High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population. Neurol Sci 33(1):33–37. doi:10.1007/s10072-011-0663-8

    Article  PubMed  Google Scholar 

  6. Association AP (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC

    Google Scholar 

  7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS–ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 34(7):939–944

    Article  CAS  PubMed  Google Scholar 

  8. Bienvenu T, Meunier C, Bousquet S, Chiron S, Richard L, Gautheret-Dejean A, Rouselle JF, Feldmann D (1999) Different procedures for the isolation of DNA from blood samples. Ann Biol Clin (Paris) 57(1):77–84

    CAS  Google Scholar 

  9. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31(3):545–548

    CAS  PubMed  Google Scholar 

  10. Alvarez-Arcaya A, Combarros O, Llorca J, Sanchez-Guerra M, Berciano J, Fernandez-Luna JL (2001) The –491TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer’s disease. Neurosci Lett 304(3):204–208

    Article  CAS  PubMed  Google Scholar 

  11. Artiga MJ, Bullido MJ, Sastre I, Recuero M, Garcia MA, Aldudo J, Vazquez J, Valdivieso F (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 421(2):105–108

    Article  CAS  PubMed  Google Scholar 

  12. Toji H, Maruyama H, Sasaki K, Nakamura S, Kawakami H (1999) Apolipoprotein E promoter polymorphism and sporadic Alzheimer’s disease in a Japanese population. Neurosci Lett 259(1):56–58

    Article  CAS  PubMed  Google Scholar 

  13. Chen L, Baum L, Ng HK, Chan LY, Sastre I, Artiga MJ, Valdivieso F, Bullido MJ, Chiu HF, Pang CP (1999) Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer’s disease. Neurosci Lett 269(3):173–177

    Article  CAS  PubMed  Google Scholar 

  14. Roks G, Cruts M, Bullido MJ, Backhovens H, Artiga MJ, Hofman A, Valdivieso F, Van Broeckhoven C, Van Duijn CM (1998) The −491A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer’s disease. Neurosci Lett 258(2):65–68

    Article  CAS  PubMed  Google Scholar 

  15. Helisalmi S, Hiltunen M, Valonen P, Mannermaa A, Koivisto AM, Lehtovirta M, Ryynanen M, Soininen H (1999) Promoter polymorphism (−491A/T) in the APOE gene of Finnish Alzheimer’s disease patients and control individuals. J Neurol 246(9):821–824

    Article  CAS  PubMed  Google Scholar 

  16. Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Perez-Tur J, Mouroux V, Mohr M, Cecyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P, Chartier-Harlin MC (1998) Pronounced impact of Th1/E47cs mutation compared with −491AT mutation on neural APOE gene expression and risk of developing Alzheimer’s disease. Hum Mol Genet 7(9):1511–1516

    Article  CAS  PubMed  Google Scholar 

  17. Casadei VM, Ferri C, Veglia F, Gavazzi A, Salani G, Cattaneo M, Sorbi S, Annoni G, Licastro F, Mariani C, Franceschi M, Grimaldi LM (1999) APOE −491 promoter polymorphism is a risk factor for late-onset Alzheimer’s disease. Neurology 53(8):1888–1889

    Article  CAS  PubMed  Google Scholar 

  18. Ahmed AR, MacGowan SH, Culpan D, Jones RW, Wilcock GK (1999) The −491A/T polymorphism of the apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer’s disease. Neurosci Lett 263(2–3):217–219

    Article  CAS  PubMed  Google Scholar 

  19. Lambert JC, Mann D, Goumidi L, Harris J, Amouyel P, Iwatsubo T, Lendon C, Chartier-Harlin MC (2001) Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer’s disease. Lancet 357(9256):608–609. doi:10.1016/s0140-6736(00)04063-0

    Article  CAS  PubMed  Google Scholar 

  20. Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC (1998) A new polymorphism in the APOE promoter associated with risk of developing Alzheimer’s disease. Hum Mol Genet 7(3):533–540

    Article  CAS  PubMed  Google Scholar 

  21. Nicodemus KK, Stenger JE, Schmechel DE, Welsh-Bohmer KA, Saunders AM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA, Martin ER (2004) Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease. Neurogenetics 5(4):201–208. doi:10.1007/s10048-004-0189-9

    Article  CAS  PubMed  Google Scholar 

  22. Roks G, Cruts M, Houwing-Duistermaat JJ, Dermaut B, Serneels S, Havekes LM, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM (2002) Effect of the APOE −491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: the Rotterdam study. Am J Med Genet 114(5):570–573. doi:10.1002/ajmg.10407

    Article  CAS  PubMed  Google Scholar 

  23. Yang JD, Feng GY, Zhang J, Cheung J, St Clair D, He L, Ichimura K (2003) Apolipoprotein E −491 promoter polymorphism is an independent risk factor for Alzheimer’s disease in the Chinese population. Neurosci Lett 350(1):25–28

    Article  CAS  PubMed  Google Scholar 

  24. Bizzarro A, Seripa D, Acciarri A, Matera MG, Pilotto A, Tiziano FD, Brahe C, Masullo C (2009) The complex interaction between APOE promoter and AD: an Italian case-control study. Eur J Hum Genet 17(7):938–945. doi:10.1038/ejhg.2008.263

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was funded by the Ministry of Higher Education and Scientific Research in Tunisia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Afef Achouri-Rassas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Achouri-Rassas, A., Hadj Fredj, S., Mrabet Khiari, H. et al. Association Between Alzheimer Disease and the −491T Allele of Regulatory Region Polymorphism of Apolipoprotein E in a Tunisian Population. Neurochem Res 39, 244–247 (2014). https://doi.org/10.1007/s11064-013-1213-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-013-1213-y

Keywords

Navigation